TRIPLE MARKER – SECOND TRIMESTER

4,830.00

Tests Details :

Home Collection

Department : BIOCHEMISTRY

The Triple Marker Test is a maternal blood screening test carried out during the second trimester of pregnancy, typically between 15 to 20 weeks. It measures the levels of three important substances in the mother’s blood:

  • Alpha-fetoprotein (AFP)
  • Human Chorionic Gonadotropin (hCG)
  • Unconjugated Estriol (uE3)

These markers help evaluate the risk of chromosomal abnormalities and neural tube defects in the fetus. It is a non-invasive screening test and does not pose any risk to the mother or baby.

The purpose of this test is to:

  • Assess the risk of chromosomal abnormalities in the fetus
  • Screen for Down syndrome (Trisomy 21)
  • Detect risk of Edwards syndrome (Trisomy 18)
  • Evaluate the likelihood of neural tube defects
  • Support early decision-making in prenatal care

Tests Prepration :

Consult your doctor. No fasting is required No special preparation needed Inform your doctor about medications or supplements Provide accurate details of gestational age and medical history Follow doctor’s instructions if any prior tests are done

The Triple Marker Test is a prenatal screening test performed during the second trimester to assess the risk of certain chromosomal abnormalities and birth defects in the developing baby.

Related Tests :

Test Name

Test Name

Test Name

2,500.00

Test Name

Test Name

Test Name